Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Novel delivery system for targeted radiotherapy of breast cancer shows promise in vitro

Jan. 21, 2010

Novel oncolytic agents described by Bristol-Myers Squibb

Jan. 20, 2010

Viralytics reports results from phase I trial of Cavatak in late-stage melanoma

Jan. 20, 2010

Boehringer and Priaxon sign collaboration for mdm2/p53 inhibitors in cancer

Jan. 20, 2010

Neural stem cells used to deliver HER2-targeting antibodies

Jan. 20, 2010

Bezafibrate-medroxyprogesterone combination active against AML

Jan. 20, 2010

Novel protein kinase inhibitors for the treatment of cancer presented by sanofi-aventis

Jan. 19, 2010

Celgene acquires Gloucester Pharmaceuticals

Jan. 19, 2010

Genentech claims checkpoint kinase Chk1 inhibitors for cancer therapy

Jan. 19, 2010

FDA extends review period for OSI's sNDA for Tarceva in non-small cell lung cancer

Jan. 19, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...